We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Chembio Diagnostics Inc | NASDAQ:CEMI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.455 | 0.44 | 0.46 | 0 | 01:00:00 |
Nevada
|
0-30379
|
88-0425691
|
||
(State or other jurisdiction
|
(Commission File Number)
|
(IRS Employer
|
||
of Incorporation)
|
Identification Number)
|
|||
3661 Horseblock Road
|
||||
Medford, NY 11763
|
||||
(Address of principal executive offices)
|
||||
631-924-1135
|
||||
(Registrant's Telephone Number)
|
Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
|
·
|
She will be paid a $25,000 annual fee (the "Annual Fee") in semi-annual payments, beginning on July 4, 2017 and continuing on each subsequent January 1 and July 1 on which she is still serving as a director.
|
·
|
She will receive a $1,000 fee for each Board meeting attended in person and a $500 for each telephonic Board meeting attended.
|
·
|
She will receive a $500 fee for attendance at each meeting attended of each Board committee of which she is a member. Committee memberships have not been determined for Ms. Page at this time.
|
·
|
On July 4, 2017 (the date on which she became a director), she received stock options to acquire, subject to vesting, 46,875 shares of the Company's common stock, with an exercise price equal to the market price on July 4, 2017. (Because July 4 is a holiday, this would be the market price on July 3, 2017.) Stock options to acquire 9,375 shares became exercisable on July 4, 2017, and stock options to acquire an additional 9,375 shares become exercisable on July 1 of each of the following four succeeding years if and to the extent she is still a director on such vesting date.
|
99.1
|
Press Release entitled "Chembio's DPP® Zika System Including the DPP® Micro Reader Approved by Brazil's Health Regulatory Agency", dated July 5, 2017.
|
99.2
|
Press Release entitled "Gail S. Page Joins Chembio Diagnostics Board of Directors", dated July 6, 2017.
|
Exhibit Number
|
Description
|
99.1
|
Press Release entitled " Chembio's DPP® Zika System Including the DPP® Micro Reader Approved by Brazil's Health Regulatory Agency", dated July 5, 2017.
|
99.2
|
Press Release entitled " Gail S. Page Joins Chembio Diagnostics Board of Directors", dated July 6, 2017.
|
1 Year Chembio Diagnostics Chart |
1 Month Chembio Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions